Meropenem Injection, Powder, For Solution
Product Images NDC 0143-9486

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Meropenem (NDC 0143-9486). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Meropenem Acs 1)

Chemical structure of meropenem, illustrating its molecular configuration, including a beta-lactam ring and side chains, represented as a hydrated form with three water molecules (·3H2O).*

FDA Label Image

Vial Label (Meropenem Acs 2)

Meropenem 500 mg per vial injection powder for solution, USP, for intravenous use only. The label states contents are sterile, single-dose vial, and prescription only. It includes storage instructions, dosage and preparation notes, manufacturer ACS Dobfar S.p.A., and labeler Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Vial Label (Meropenem Acs 3)

Label for Meropenem injection, USP, 1 gram per vial, for intravenous use only. The sterile single-dose vial is manufactured by ACS Dobfar S.p.A. and labeled by Hikma Pharmaceuticals USA Inc. The label includes storage instructions, dosing and administration notes, and manufacturer details, along with barcodes and spaces for lot and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.